In an endeavour to encourage health innovations in India and Africa, a conclave was organised by the Public Health Foundation of India (PHFI), Amref Africa, the Institute of Development Studies, UK (IDS UK), Indian Institute of Public Health Gandhinagar in partnership with NITI Aayog. This event was hosted at the GE Healthcare Centre in Bengaluru.
The National Institutes of Health plans to end funding to Moderate Alcohol and Cardiovascular Health (MACH) trial. National Institute of Alcohol Abuse and Alcoholism (NIAAA) funding for the MACH trial will end within the next few months following completion of an orderly closeout.
The central government has ordered pharmacies to display generic drugs on separate shelves so that consumers can opt for generic medicine to expensive brand name drugs.
Drug Comptroller General has issued a letter to all states and union territories to provide a shelf for display of generic medicines.
[adsense:336x280:8701650588]
WHO published its first Essential Diagnostics List, a catalogue of the tests needed to diagnose the most common conditions as well as a number of global priority diseases.
The Indian Ocean Rim Association - Regional Centre for Science and Technology Transfer (IORA-RCSTT) Coordination Centre was inaugurated on 7 May 2018 at the Central Institute of Medicinal and Aromatic Plants (CIMAP) campus of the Council of Scientific and Industrial Research (CSIR) in Lucknow.
[adsense:336x280:8701650588]
The International Diabetes Federation (IDF) estimates that there are 72.9 million
people with diabetes in India in 2017, which is projected to rise to 134.3 million by the
year 2045. The prevalence of diabetes in urban India, especially in large metropolitan
cities has increased from 2% in the 1970s to over 20% at present and the rural areas
are also fast catching up.
Government takes obligatory action for collecting data of all tuberculosis patients to ensure proper tuberculosis diagnosis and its management in patients and their contacts and to reduce tuberculosis transmission and further to address the problems of emergence and spread of Drug Resistant-Tuberculosis.
Government of India brings Tramadol, a synthetic opioid pain killer, under the control of the Narcotic Drugs and Psychotropic Substances (NDPS) Act 1985. Tramadol is also known as ISIS Drug. ISIS militants are known to abuse tramadol to suppress pain and boost strength during injury. International anti-narcotics authorities also called it as fighter drug.
Indian and foreign pharmaceutical associations need amendment in section 146 of Indian patent act 1970 and form 27 for making Indian patenting system more efficient and it will eliminate vague and unnecessary annual working statement disclosures. Indian patent office has invited responses from stake holders and many pharmaceutical industries and association responded in this regards.
Japan continues to be one of the largest pharmaceutical markets in the globe only behind US and China. The country of 12-13 crores population and have greatest potential in pharmaceutical despite difficult demographic landscape. Life expectancy of Japanese population is higher in the world which is almost 80 years for male and 87 years for female. Older people need more medicine and this is the fundamental of pharmaceutical industry in the Japan.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
